688575 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Shenzhen YHLO Biotech Co., Ltd. engages in the research, development, production and sales of in vitro diagnostic instruments and supporting reagents based on chemiluminescence immunoassay solution for diagnosis of autoimmune diseases, reproductive health, and infectious diseases. It focuses on healthcare and better life with technology. The company was founded on September 17, 2008 and is headquartered in Shenzhen, China. .
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
688575 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company